COMMUNIQUÉS West-GlobeNewswire

Dermira Announces Proposed Public Offering of Common Stock
18/03/2019
MENLO PARK, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Syneos Health Reports Fourth Quarter and Full Year 2018 Results
18/03/2019
Highlights GAAP total revenue of $1.15 billion and $4.39 billion for the fourth quarter and year ended December 31, 2018, respectively. Adjusted service revenue under ASC 606 of $1.15 billion and $4.40 billion for the [...]
Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
18/03/2019
CORAL GABLES, Fla., March 18, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
resTORbio, Inc. Announces Proposed Public Offering of Common Stock
18/03/2019
BOSTON, March 18, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. ("resTORbio" or the "Company") (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to [...]
Additional Real-World Data Show a Significant Risk Increase in Cardiovascular Events in People with Elevated Triglyceride Levels
18/03/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, March 18, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, announced today that real-world data [...]
Opiant Pharmaceuticals to Report Fiscal 2018 Financial Results and Host Conference Call and Webcast on Thursday, March 21
18/03/2019
SANTA MONICA, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced [...]
electroCore to Announce Fourth Quarter and Year Ended December 31, 2018 Financial Results on Wednesday, March 27
18/03/2019
Conference Call to be Held at 4:30pm Eastern Time BASKING RIDGE, N.J., March 18, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it will [...]
Dynavax Exercises Option for $75 Million in Non-Dilutive Debt
18/03/2019
Proceeds to fund HEPLISAV-B® commercialization activities and completion of ongoing immuno-oncology studies BERKELEY, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX) today [...]
IRIDEX to Present at the Spring Investor Summit
18/03/2019
MOUNTAIN VIEW, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to present at the upcoming Spring Investor Summit in New York, NY. Chairman and CEO William [...]
Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results
18/03/2019
CANTON, Mass. , March 18, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
Novavax Reports Fourth Quarter and Year-End 2018 Financial Results
18/03/2019
Company to Host Conference Call Today at 4:30 p.m. ET GAITHERSBURG, Md., March 18, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth [...]
HealthEquity Reports Fourth Quarter and Fiscal Year Ended January 31, 2019 Financial Results
18/03/2019
Highlights of the fiscal year include: Revenue of $287.2 million, an increase of 25% compared to FY18. Net income of $73.9 million, an increase of 56% compared to FY18. Net income per diluted share of $1.17, compared to [...]
Evolus Reports Fourth Quarter and Full Year 2018 Results
18/03/2019
Received U.S. FDA Approval of Jeuveau™ on February 1, 2019 Majority of Sales Force Hired with Launch Planned in the Coming Weeks Hosting Investor & Analyst Day on May 8 th , 2019 in New York, NY NEWPORT BEACH, Calif [...]
CohBar Reports Fourth Quarter 2018 Financial Results and Provides Business Update
18/03/2019
MENLO PARK, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported [...]
Evolus Secures $100 Million Senior Debt Facility with Oxford Finance LLC
18/03/2019
Provides Non-Dilutive Financing and Increased Flexibility Ahead of Jeuveau™ U.S. Launch NEWPORT BEACH, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer [...]
iCAD Reports Fourth Quarter and Full-Year 2018 Financial Results
18/03/2019
Company achieved key milestone in fourth quarter with FDA clearance and subsequent U.S. commercial launch of ProFound AI™ for digital breast tomosynthesis Conference call today at 4:30 p.m. ET NASHUA, N.H. , March 18, [...]
resTORbio Reports Fourth Quarter and Full Year 2018 Financial Results
18/03/2019
Positive End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA); Phase 3 program of RTB101 expected to initiate in 2Q19 Phase 1b/2a trial of RTB101 in combination with sirolimus in Parkinson’s disease ( [...]
Cytokinetics Announces Presentation of Additional Results From COSMIC-HF at ACC.19
18/03/2019
No Difference in Treatment Effects of Omecamtiv Mecarbil in Patients with Heart Failure Irrespective of Atrial Fibrillation SOUTH SAN FRANCISCO, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated ( [...]
IntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 25, 2019 – Conference Call to Follow
18/03/2019
SAINT LAURENT, Quebec, March 18, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) today announced that it will release its fourth quarter and full year 2018 financial results after [...]

Pages